U.S. Army Medical Research & Development Command

What U.S. Army Medical Research & Development Command does

USAMRDC is the biomedical research command of the U.S. Department of Defense, operating under the Defense Health Agency and headquartered at Fort Detrick, Maryland. It runs six specialized laboratories — USAMRIID, WRAIR, USAMRICD, USAISR, USARIEM, and USAARL — alongside the Congressionally Directed Medical Research Programs (CDMRP), which together cover combat casualty care, infectious diseases (including HIV and malaria countermeasure development), military operational medicine, chemical and biological defense, environmental and thermal medicine, and aeromedical research. Outputs include FDA-cleared decision-support AI tools such as APPRAISE-HRI for hemorrhage resuscitation, FDA-cleared and fielded devices such as the SAM Junctional Tourniquet, immersive training prototypes using mixed-reality headsets, and the HIPAA/HIPPS-type software suites that bridge frontline medics to higher-echelon care.

The command's business model is non-commercial: it is funded entirely through annual congressional appropriations routed via the Defense Health Program and supplemented by Congressionally Directed Medical Research Programs. Its sole primary customer is the U.S. military, with the Department of Defense serving as the anchor buyer and end-user base of military service members. Limited technology-licensing arrangements, such as the partnership with First Line Technology for the Bio-Containment System and SBIR-funded work with commercial vendors like Zeteo Tech, represent the principal pathway by which selected USAMRDC-developed capabilities reach private-sector markets. Strategic direction is set under Commanding General BG Constance L. Jenkins (as of July 2026), with Dr. Carrie M. Quinn serving as deputy and CSM Curtis C. Conklin as senior enlisted advisor.

Name

U.S. Army Medical Research & Development Command

Legal name

U.S. Army Medical Research and Development Command

Website

https://mrdc.health.mil

Company type

Public

Founded year

1992

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

The U.S. Army Medical Research & Development Command is a DoD biomedical research organization operating six specialized laboratories and the CDMRP, developing medical countermeasures, devices, and FDA-cleared AI decision-support tools to protect and treat U.S. military warfighters.

Ownership category

akta.pro rank

Product category

Defense Biomedical Research

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

akta.pro secondary industries

Infectious Disease & Pandemic Preparedness Vaccines (emerging pathogens) (HLAAAEAC), Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• Military biomedical research
• Combat casualty care
• Infectious disease research
• Military medical readiness
• Chemical biological defense

Headquarters

HQ city

Frederick

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Federal Government Appropriations: The command operates as a U.S. Department of Defense organization funded through federal budget appropriations to advance military health and readiness through biomedical research

Distribution channels3 records

Marketing channels6 records

Core offering

USAMRDC conducts cutting-edge biomedical research through six medical research laboratories (USAMRIID, WRAIR, USAMRICD, USAISR, USARIEM, USAARL) and CDMRP to develop life-saving medical technologies, vaccines, therapeutics, diagnostics, and decision-support tools that protect and sustain the health of U.S. Warfighters across combat casualty care, infectious diseases, chemical/biological defense, environmental medicine, and aeromedical research.

Product overview

DHA R&D-MRDC is a multi-institute biomedical research command that does not offer a single unified product but rather operates a portfolio of specialized research laboratories producing distinct products, technologies, and decision-support tools. The command's subordinate institutes develop targeted medical solutions: USAISR (combat casualty care) produces the SAM Junctional Tourniquet and explores mixed reality for burn care; USAMRIID (infectious diseases) develops vaccines, therapeutics, and the novel antibody discovery platform; USAMRICD (chemical defense) produces bio-scavenger pretreatments and ChemDx diagnostics; USARIEM (environmental medicine) delivers the Heat Injury Prevention Prediction System, Individual Heat Optimization Training Tool, and Cold Weather Ensemble Decision Aid; USAARL (aeromedical research) develops blast exposure monitoring and crashworthy seat technologies. CDMRP serves as a separate research funding mechanism. Key FDA-cleared AI-enabled products include APPRAISE-HRI for hemorrhage triage. The portfolio includes licensed technologies like the Body Cooling System and CAPS hearing protection. The organization emphasizes technology transfer through its Medical Technology Transfer Office to commercialize innovations.

Differentiator

Problem solved

Functional benefit

Products and services

• APPRAISE-HRI (APPRAISE Hemorrhage Risk Indicator) FDA-cleared AI-enabled decision-support software application used by military health care providers to stratify hemorrhage risk of U.S. Service Members after a traumatic event. The first AI software cleared by FDA for hemorrhage triage of combat casualties.
• SAM Junctional Tourniquet Combat casualty care medical device developed by USAISR that addresses bleeding in areas where traditional tourniquets cannot be used, designed for battlefield injuries.
• Heat Injury Prevention Prediction System (HIPPS) Decision-support tool using real-time environmental data and physiological markers to predict heat injury risk before it occurs, allowing commanders to proactively adjust training intensity, hydration, or rest cycles. Currently deployed at Sapper School and the U.S. Marine Corps.
• Individual Heat Optimization Training Tool USARIEM-developed assessment tool that assesses exertional heat illness risk to optimize soldier training in extreme environments and protect health and performance.
• Cold Weather Ensemble Decision Aid USARIEM-developed decision aid that provides guidance on clothing selection for freezing conditions to ensure warfighters can perform effectively in cold environments while minimizing injury risk.
• Body Cooling System (BCS) Heat-exhaustion prevention device consisting of a shallow standing water basin that allows sufferers to submerge hands and forearms to reduce core body temperature. Licensed to First Line Technology, LLC; can increase capacity to work in hot, humid environments by up to 60%.
• Canine Auditory Protection System (CAPS) Hearing protection headgear for military working dogs that blocks unwanted sounds while preserving the animal's ability to hear verbal commands; developed through SBIR partnership with Zeteo Tech, Inc. and University of Cincinnati FETCHLAB.
• Blast Exposure Monitoring Tool USAARL-developed wearable and environmental sensor system that monitors blast exposure and head acceleration impacts, enabling early detection of concussive events during military training and operations.
• ChemDx Field Diagnostic System USAMRICD-developed field diagnostic system for detecting chemical exposure, supporting chemical casualty care and chemical warfare defense operations.
• VISTA Casualty Detection and Assessment Systems TATRC-developed automated casualty detection and assessment system for battlefield medicine, tested at Project Convergence Capstone 5.
• Bio-Scavenger Pretreatments for Nerve Agent Exposure USAMRICD-developed prophylactic pretreatment that provides protection against nerve agent exposure for up to two weeks, enhancing soldier safety in chemical threat environments.
• Rapid Opioid Countermeasure System USAMRICD-developed naloxone auto-injector designed to rapidly treat opioid intoxication in military settings as part of chemical casualty care capabilities.

Quantifiable outcome

• Heat exhaustion prevention device (BCS) can increase capacity to work in hot, humid environments by up to 60%
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability21 records

Feature10 records

Partnerships

15 partnerships are on record, tiered core.

• First Line Technology, LLCcoreOEM/ Whitelabel/ Licensing Partner · 24 November 2020Technology licensing partnership for the Body Cooling System (BCS) - a shallow standing water basin for hand/forearm immersion cooling to reduce core body temperature. The BCS can increase capacity to work in hot, humid environments by up to 60%. First Line Technology is ISO 9001:2015 certified in disaster preparedness and emergency response equipment.
• Zeteo Tech, Inc.coreStrategic or Co-development PartnerSBIR-funded development partner for the Canine Auditory Protection System (CAPS). Zeteo Tech developed the hearing protection headgear for military working dogs in collaboration with USAMRDC, designed to block harmful sounds while maintaining ability to hear commands.
• University of Cincinnati FETCHLABcoreStrategic or Co-development PartnerCollaboration with Dr. Pete Scheifele at UC's FETCHLAB (leading animal audiology expert) for development of the Canine Auditory Protection System. Dr. Scheifele identified hearing loss issues in military working dogs and co-developed the solution.
• U.S. Army Research Office (ARO)coreStrategic or Co-development PartnerFacilitated initial collaboration between Zeteo Tech and University of Cincinnati researchers, providing Small Business Innovation Research guidance and expertise on military working dog veterinary issues.
• U.S. Army Combat Readiness CentercoreStrategic or Co-development PartnerData partnership for USAARL crashworthiness research - analyzing real-world injury patterns and outcomes from helicopter crashes to inform seat design standards.
• U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)coreStrategic or Co-development PartnerDirect reporting unit specializing in bio-terror threat mitigation and infectious disease research, developing vaccines, therapeutics, and diagnostics for pathogens including anthrax, Ebola, and Marburg virus.
• Walter Reed Army Institute of Research (WRAIR)coreStrategic or Co-development PartnerDoD's largest and most diverse biomedical research institute specializing in infectious diseases, brain health, and Soldier performance optimization. Led development of nearly all FDA-approved antimalarial drugs and world's largest HIV vaccine efficacy trial.
• U.S. Army Institute of Surgical Research (USAISR)coreStrategic or Co-development PartnerWorld's leading institute for combat casualty care research, developing life-saving medical innovations for battlefield injuries including the SAM Junctional Tourniquet and burn care advances.
• U.S. Army Medical Research Institute of Chemical Defense (USAMRICD)coreStrategic or Co-development PartnerLeading institute for medical chemical defense research, developing bio-scavenger pretreatments for nerve agent exposure and the Rapid Opioid Countermeasure System (naloxone auto-injector).
• U.S. Army Research Institute of Environmental Medicine (USARIEM)coreStrategic or Co-development PartnerResearch institute optimizing Soldier health and performance in extreme environments (heat, cold, altitude). Developed the Individual Heat Optimization Training Tool and Cold Weather Ensemble Decision Aid.
• U.S. Army Aeromedical Research Laboratory (USAARL)coreStrategic or Co-development PartnerSpecializing in aviation Soldier safety and performance, conducting research on acoustics, vision, blast exposure, and aeromedical devices. Environmental Sensors in Training program monitors blast exposure and head acceleration impacts.
• Defense Health AgencycoreStrategic or Co-development PartnerParent organization for DHA R&D-MRDC, overseeing military health system governance and research direction.
• Sapper SchoolcoreStrategic or Co-development PartnerOperational deployment of the Heat Injury Prevention Prediction System (HIPPS) for heat injury risk assessment.
• U.S. Marine CorpscoreStrategic or Co-development PartnerDeployment of HIPPS heat injury prevention technology and integration into the upcoming Best Medic Competition.
• MITcoreStrategic or Co-development PartnerPartnership on AI tool development for nerve block anesthetics in collaboration with USAISR.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• RTI International: Independent nonprofit research institute performing health, biomedical, and pharmaceutical research with significant government funding. Comparable scale and scope in conducting government-sponsored life science R&D and clinical research.
• SRI International: Independent nonprofit research institute performing biomedical, pharmaceutical, and defense research for government and commercial clients. Comparable as a multi-disciplinary R&D organization delivering regulated medical products and government-funded science.
• National Institutes of Health (NIH): U.S. government's largest biomedical research funder, with comparable R&D output (vaccines, therapeutics, clinical trials) and similar government-funded model. Comparable in research scope and ability to translate discoveries into clinical products.
• Defense Advanced Research Projects Agency (DARPA): DoD research agency funding high-risk, high-reward technology development including biomedical programs (e.g., battlefield medicine, prosthetics). Sibling organization to USAMRDC within the broader DoD research ecosystem with overlapping aims in defense-relevant medical innovation.
• Battelle Memorial Institute: Large nonprofit applied science R&D organization that manages FFRDCs and conducts biomedical, chemical, and defense research for federal agencies. Operates at a similar scale to USAMRDC in multi-disciplinary government-funded life science and medical research.
• Biomedical Advanced Research Development Authority (BARDA): HHS agency that funds advanced development of medical countermeasures (vaccines, therapeutics, diagnostics) against CBRN threats, pandemic influenza, and emerging infectious diseases. Direct functional overlap with USAMRDC/WRAIR/USAMRIID work on vaccines and pandemic preparedness.

Emerging players

• Charles River Laboratories: Leading CRO providing preclinical research, biologics, and laboratory services to government and biopharma clients. Comparable in life science research services and infectious disease/vaccine testing capabilities relevant to USAMRDC's mission.
• Lovelace Biomedical: Contract research organization specializing in preclinical, inhalation, and infectious disease research with deep government and DoD client relationships. Comparable niche focus on regulated preclinical and CBRN-related biomedical research.

Direct peers

• Naval Medical Research Center (NMRC): U.S. Navy's flagship biomedical research command, operating under Navy Medicine. NMRC conducts infectious disease research, combat casualty care, and operational medicine for Sailors and Marines, making it the closest DoD counterpart to USAMRDC in mission and structure.
• Air Force Research Laboratory - 711th Human Performance Wing: The U.S. Air Force's primary biomedical and human performance research unit, focused on aerospace medicine, operational readiness, and pilot/aircrew health. Highly comparable to USAMRDC in mission (military health R&D) and structure (subordinate labs within a parent command).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/USARIEM
• LinkedInlinkedin.com/company/u-s-army-medical-research-and-development-command

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments8 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about U.S. Army Medical Research & Development Command